LHC Annual Bibliography

(2008-2009)

 

Ambs, S., Marincola, F.M., and Thurin, M. Meeting Report: Profiling of immune response to guide cancer diagnosis, prognosis, and prediction to therapy.  Cancer Res., 68: 4031-4033, 2008.

 

Ambs, S., Prueitt, R.L., Yi, M., Hudson, R.S., Howe, T.M., Petrocca, F., Wallace, T.A., Liu, C.-G., Volinia S., Calin, G.A., Yfantis, H.G., Stephens, R.M., and Croce, C.M. Genomic profiling of microRNA and mRNA reveals deregulated microRNA expression in prostate cancer.  Cancer Res., 68: 6162-6170, 2008.

 

Ambs, S., Wolpert, B., Loffredo, C. A., Zheng, Y. L., Shields, P. G., Jones, R. and Harris, C. C.: Occupation, gender, race, and lung cancer. JOEM, 50: 1167-1175, 2008.

 

Boersma, B.J., Reimers, M., Yi, M., Ludwig, J.A., Luke, B.T., Stephens, R.M., Yfantis, H.G., Lee, D.H., Weinstein, J.N., and Ambs, S. A stromal gene signature associated with inflammatory breast cancer.  Int. J. Cancer, 122: 1324-1332, 2008.

 

Brosh, R., Shalgi, R., Liran, A., Landan, G., Korotayev, K., Nguyen, G. H., Enerly, E., Johnsen, H., Buganim, Y., Solomon, H., Goldstein, I., Madar, S., Goldfinger, N., B¿rresen-Dale, A. L., Ginsberg, D., Harris, C. C., Pilpel, Y., Oren, M. and Rotter, V.: p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol. 4: 229, 2008.

 

Budhu, A., Jia, H.L., Forgues, M., Liu, C.G., Goldstein, D., Lam, A., Zanetti, K.A., Ye, Q.H., Qin, L.X., Croce, C.M., Tang, Z.Y., Wang, X.W. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology, 47, 897-907, 2008

 

Hussain, S. P., He, P., Subleski, J., Hofseth, L. J., Trivers, G. E., Mechanic, L., Hofseth, A. B., Bernard, M., Schwank, J., Nguyen, G., Mathe, E., Djurickovic, D., Haines, D., Weiss, J., Back, T., Gruys, E., Laubach, V. E., Wiltrout, R. H. and Harris, C. C.: Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res., 68: 7130-7136, 2008.

 

Kumamoto, K., Spillare, E. A., Fujita, K., Horikawa, I., Yamashita, T., Appella, E., Nagashima, M., Takenoshita, S., Yokota, J. and Harris, C. C.: Nutlin-3a activates p53 to both down-regulate ING2 and up-regulate mir-34a, b and c expression and induces senescence. Cancer Res., 68: 3193-3203, 2008.

 

Martin, R. C., Barker, D. F., Doll, M. A., Pine, S. R., Mechanic, L., Bowman, E. D., Harris, C. C. and Hein, D. W.: Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population. DNA Cell Biol., 27: 321-323, 2008.

 

Mechanic, L. E., Luke, B. T., Goodman, J. E., Chanock, S. J. and Harris, C. C.: Polymorphism interaction analysis (PIA): a method for investigating complex gene-gene interactions. BMC Bioinformatics, 9:146, 2008.

 

Prueitt, R.L., Yi, M., Hudson, R.S., Wallace, T.A., Howe, T.M., Yfantis, H.G., Stephens, R.M., Liu, C.-G., Calin, G.A., Croce, C.M., and Ambs, S. MicroRNA and mRNA expression profiles associated with perineural invasion in prostate cancer.  The Prostate, 68, 1152-1164, 2008.

 

Ridnour, L.A., Thomas, D.D., Switzer, C.H., Flores-Santana, W., Isenberg, J.S., Ambs, S., Roberts, D.D., and Wink, D.A. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide, 19: 73-76, 2008.

 

Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D.L.W., Au, G. K. H., Liu, C. G., Calin, G. A., Croce, C. M. and Harris, C. C.: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299: 425-436, 2008.

 

Thomas, D.D., Ridnour, L.A., Isenberg J.S., Flores-Santana, W., Switzer C.H., Donzellie S., Hussain, S.P., Vecoli C., Paolocci N., Ambs S., Colton C., Harris C.C., Roberts, D.D., and Wink, D.A.: The chemical biology of nitric oxide: Implications in cellular signaling.  Free Radic. Biol. Med., 45, 18-31, 2008.

 

Unoki, M., Kumamoto, K., Robles, A. I., Shen, J. C., Zheng, Z. M. and Harris, C. C.: A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis. FEBS Letter 582: 3868-3874, 2008.

 

Vanmeter, A. J., Rodriguez, A. S., Bowman, E. D., Harris, C. C., Deng, J., Calvert, V. S., Silvestri, A., Fredolini, C., Chandhoke, V., Petricoin, E. F., 3rd, Liotta, L. A. and Espina, V.: LCM and protein microarray analysis of human NSCLC: Differential EGFR phosphorylation events associated with mutated EGFR compared to wild type. Mol Cell Proteomics 7: 1902-1924, 2008.

 

Wang, R.H., Sengupta, K., Li, C., Kim, H.S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., Zheng, Z.M., Wang, X.W., Ried, T., Deng, C.X. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell, 14, 312-23, 2008.

 

Wallace, T.A., Prueitt, R.L., Yi, M., Howe, T.M., Gillespie, J.W., Yfantis, H.G., Stephens, R.M., Caporaso, N.E., Loffredo, C.A., and Ambs, S. Tumor immunobiological differences in prostate cancer between African-American and European-American men.  Cancer Res., 68: 927-936, 2008.

 

 

Yamashita, T., Forgues, M., Kim, J.W., Wang, W., Ye, Q.H., Jia, H.L., Budhu, A., Takafuji, V.A., Zanetti, K., Chen, Y., Qin, L.X., Tang, Z.Y., Wang, X.W. EpCAM and a-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res, 68, 1451-61, 2008

 

 

2009

 

 

Dong, F., Budhu, A., Wang, X.W. Translating the Metastasis Paradigm from Scientific Theory to Clinical Oncology.  Clin Cancer Res, 15, 2588-93, 2009.

 

Enewold, L., Mechanic, L. E., Bowman, E. D., Zheng, Y. L., Yu, Z., Trivers, G., Alberg, A. J. and Harris, C. C.: Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. CEBP 18: 215-222, 2009.

 

Fujita, K., Mondal, A. M., Horikawa, I., Nguyen, G. H., Kumamoto, K., Sohn, J. J., Bowman, E. D., Mathe, E. A., Schetter, A. J., Pine, S. R., Ji, H., Vojtesek, B., Bourdon, J. C., Lane, D. P. and Harris, C. C.: p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol. 11: 1135-1142, 2009.

 

Glynn, S.A., Boersma, B.J., Howe, T.M., Edvardsen, H., Geisler, S.B., Goodman, J.E., Ridnour, L.A., L¿nning, P.E., B¿rresen-Dale, A.-L., Naume, B., Kristensen, V.N., Chanock, S.J., Wink, D.A., and Ambs, S. A mitochondrial target sequence polymorphism in the MnSOD gene predicts poor response and inferior survival in breast cancer patients treated with cyclophosphamide. Clin. Cancer Res., 15: 4165-4173, 2009.

 

Hung, R. J., Christiani, D. C., Risch, A., Popanda, O., Haugen, A., Zienolddiny, S., Benhamou, S., Bouchardy, C., Lan, Q., Spitz, M. R., Wichmann, H. E., LeMarchand, L., Vineis, P., Matullo, G., Kiyohara, C., Zhang, Z. F., Pezeshki, B., Harris, C., Mechanic, L., Seow, A., Ng, D. P., Szeszenia-Dabrowska, N., Zaridze, D., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Foretova, L., Janout, V., Bencko, V., Caporaso, N., Chen, C., Duell, E. J., Goodman, G., Field, J. K., Houlston, R. S., Hong, Y. C., Landi, M. T., Lazarus, P., Muscat, J., McLaughlin, J., Schwartz, A. G., Shen, H., Stucker, I., Tajima, K., Matsuo, K., Thun, M., Yang, P., Wiencke, J., Andrew, A. S., Monnier, S., Boffetta, P. and Brennan, P.: International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev., 17: 3081-3089, 2008.

 

 

Ji, J., Yamashita, T., Budhu, A., Forgues, M., Jia, H.L. Li, C., Deng, C., Wauthier, E., Reid, L.M., Ye, Q.H., Qin, L.X., Yang, W., Wang, H.Y., Tang, Z.Y., Croce, C.M. and Wang, X.W. Identification of MicroRNA-181 by Genome-Wide Screening as a Critical Player in Epithelial Cell Adhesion Molecule–Positive Hepatic Cancer Stem Cells. Hepatology, 50, 472-80, 2009.

 

Ji, J. and Wang, X.W. New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma. Cancer Biology & Therapy, 8, 1-8, 2009

 

Ji. J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S., Ambs, S., Chen, Y., Meltzer, P.S., Croce, C.M., Qin, L.X., Man, K., Lo, C.M., Lee, J., Ng, I.O.L., Fan, J., Tang, Z.Y., Sun, H.C., Wang, X.W. MicroRNA expression, survival, and response to interferon in men and women with liver cancer. N Engl J Med, 361, 1437-47, 2009

 

Jones, P.E., Ying, L., Hofseth, A.B., jelezcova, E., Sobol, R.W., Ambs S., Harris, C.C., Espey, M.G., Hofseth L.J., and Wyatt, M.D. Differential effects of reactive nitrogen species on DNA base excision repair initiated by the alkyladenine DNA glycosylase. Carcinogenesis, 2009: (Epub).

 

Kumamoto, K., Fujita, K., Kurotani, R., Saito, M., Unoki, M., Hagiwara, N., Shiga, H., Bowman, E. D., Yanaihara, N., Okamura, S., Nagashima, M., Miyamoto, K., Takenoshita, S., Yokota, J. and Harris, C. C.: ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. Int. J. Cancer, 125: 1306-1315, 2009.

 

Martin, D.N., Boersma, B.J., Yi, M., Reimers, M., Howe, T.M., Yfantis, H.G., Tsai, Y.C., Williams, E.H., Lee, D.H., Stephens, R.M., Weissman, A.M, and Ambs S. Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One, 4: e4531, 2009.

 

Mathe, E.A., Nguyen, G.H., Bowman, E.D., Zhao, Y., Budhu, A., Schetter, A.J., Braun, R., Reimers, M., Kumamoto, K., Hughes, D., Altorki, N.K., Casson, A.G., Liu, C.G., Wang, X.W., Yanaihara, N., Hagiwara, N., Dannenberg, A.J., Miyashita, M., Croce, C.M., Harris, C.C. MiRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus and associations with survival. Clin Cancer Res, 15, 6192-200, 2009

 

Schetter, A. J., Nguyen, G. H., Bowman, E. D., Mathe, E. A., Yuen, S. T., Hawkes, J. E., Croce, C. M., Leung, S. Y. and Harris, C. C.: Association of inflammation-related and microRNA gene expression with cancer specific mortality of colon adenocarcinoma. Clin Cancer Res, 15: 5878-5887, 2009.

 

Seike, M., Goto, A., Okano, T., Bowman, E. D., Schetter, A. J., Horikawa, I., Mathe, E. A., Jen, J., Yang, P., Sugimura, H., Gemma, A., Kudoh, S., Croce, C. M. and Harris, C. C.: MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci USA, 106: 12085-12090, 2009.

 

Simone, N. L., Soule, B. P., Ly, D., Saleh, A. D., Savage, J. E., Degraff, W., Cook, J., Harris, C. C., Gius, D. and Mitchell, J. B.: Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One, 4: e6377, 2009.

 

Tahara, H., Sato, M., Thurin, M., Wang, E., Butterfield, L.H., Disis, M.L., Fox, B.A., Lee, P.P., Khleif, S.N., Wigginton, J.M., Ambs, S., Akutsu, Y., Chaussabel, D., Doki, Y., Eremin, O., Fridman, W.H., Hirohashi,Y., Imai, K., Jacobson, J., Jinushi, M., Kanamoto, A., Kashani-Sabet, M., Kato, K., Kawakami, Y., Kirkwood, J.M., Kleen, T.O., Lehmann, P.V., Liotta, L., Lotze, M.T., Maio, M., Malyguine, A., Masucci, G., Matsubara, H., Mayrand-Chung, S., Nakamura, K., Nishikawa, H., Palucka, A.K., Petricoin, E.F., Pos, Z., Ribas, A., Rivoltini, L., Sato, N., Shiku, H., Slingluff, C.A., Streicher, H., Stroncek, D.F., Takeuchi, H., Toyota, M., Wada, H., Wu, X., Wulfkuhle, J., Yaguchi, T., Zeskind, B., Zhao, Y., Zocca, M.B., and Marincola, F.M. Emerging concepts in biomarker discovery; The US-Japan Workshop on immunological molecular markers in oncology. J Transl. Med., 17:45, 2009.

 

Wang, X.W. and Thorgeirsson, S.S. Transcriptome analysis of liver cancer: Ready for the clinic? J Hepatology, 50, 1060-4, 2009.

 

Wang, X.W. and Thorgeirsson, S.S. Genome-based predictors for HCC outcomes: A matter of tumor and/or stroma. J Hepatology, 51, 596-7, 2009.

 

Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., Reid, L., Minato, H., Honda, M., Kaneko, S., Tang, Z., Wang, X.W. EpCAM-positive hepatocellular carcinoma cells are tumor initiating cells with stem/progenitor cell features. Gastroenterology, 136, 1012-24, 2009. 

 

Zeng, S., Xiang, T., Pandita, T. K., Gonzalez-Suarez, I., Gonzalo, S., Harris, C. C. and Yang Q.: Telomere recombination requires the MUS81 endonuclease. Nat Cell Biol., 11: 616-623, 2009.